Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|67|3|386-397

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.67, Iss.3, 2015-09, pp. : 386-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D Receptor Is Expressed in Pancreatic Cancer Cells and a Vitamin D3 Analogue Decreases Cell Number

By  

Pancreatology, Vol. 3, Iss. 1, 2003-03 ,pp. : 41-46

Karger

Access to resources Recommend Favorite

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: Analysis of CD G870A polymorphism, FISH and immunohistochemistry

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 3, 2015-03 ,pp. : 316-323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fatty Acid Synthase Is a Potential Therapeutic Target in Estrogen Receptor-/Progesterone Receptor-Positive Endometrioid Endometrial Cancer

By  

Oncology, Vol. 84, Iss. 3, 2013-01 ,pp. : 166-173

Karger

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: A Potential Therapeutic Role for Gastrin-Releasing Peptide Receptor Antagonists

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 160-161

Karger

Access to resources Recommend Favorite

Role of Epidermal Growth Factor Receptor Expression on Patient Survival in Pancreatic Cancer: A Meta-Analysis

By  

Pancreatology, Vol. 11, Iss. 6, 2012-01 ,pp. : 595-600

Karger

Access to resources Recommend Favorite